These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6244899)

  • 1. C3-activating proteases on human lymphoblastoid cells superinfected with Epstein-Barr Virus.
    Schulz T; Dierich MP; Yefenof E; Klein G
    Cell Immunol; 1980 Apr; 51(1):168-72. PubMed ID: 6244899
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.
    McConnell I; Klein G; Lint TF; Lachmann PJ
    Eur J Immunol; 1978 Jul; 8(7):453-8. PubMed ID: 211040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of Epstein-Barr virus (EBV) receptors on B lymphocytes from certain patients with common varied agammaglobulinemia.
    Schwaber JF; Klein G; Ernberg I; Rosen A; Lazarus H; Rosen FS
    J Immunol; 1980 May; 124(5):2191-6. PubMed ID: 6245136
    [No Abstract]   [Full Text] [Related]  

  • 4. Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells.
    Jondal M; Klein G; Oldstone MB; Bokish V; Yefenof E
    Scand J Immunol; 1976; 5(4):401-10. PubMed ID: 59946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in expression of mouse erythrocyte receptors on Epstein-Barr virus-induced B-cell lines.
    Youinou PY; Walker PR; Irving WL; Lydyard PM
    Immunol Lett; 1984; 8(1):27-32. PubMed ID: 6086504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus susceptibility of normal human B lymphocyte populations.
    Aman P; Ehlin-Henriksson B; Klein G
    J Exp Med; 1984 Jan; 159(1):208-20. PubMed ID: 6319530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Epstein-Barr virus-coded antigens in lymphocytes isolated from defined patient samples.
    Veltri RW; McClung JE; Sprinkle PM
    IARC Sci Publ (1971); 1978; (24 Pt 2):729-32. PubMed ID: 221395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superinfection by Epstein-Barr virus of a subset of Raji cells is independent of HLA class II-antigens.
    Faggione A; Zompetta C; Cirone M; Barile G; Frati L; Acolla R
    Int J Cancer; 1990 May; 45(5):989. PubMed ID: 2159443
    [No Abstract]   [Full Text] [Related]  

  • 9. [C3 receptor expression in lymphocytes].
    Kudo T; Okuda T; Tachibana T
    Nihon Rinsho; 1979 May; 37(5):993-1001. PubMed ID: 224224
    [No Abstract]   [Full Text] [Related]  

  • 10. [Production of human monoclonal antibodies by Epstein-Barr virus-transformed cell lines].
    Avital A; Steinitz M
    Harefuah; 1984 Oct; 107(7-8):167-8. PubMed ID: 6097516
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenotype characteristics of human B cells studied by Epstein-Barr virus infection. II. C3 receptor switching during human B cell differentiation.
    Kudo T; Tachibana T
    Immunol Lett; 1984; 8(6):343-8. PubMed ID: 6098555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
    Tsukuda K; Berczi I; Klein G
    J Immunol; 1981 May; 126(5):1810-3. PubMed ID: 6260858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T; Holly RD; Clark EA
    J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalized human B-cell line GM607 but do not confer tumorigenicity.
    Tomlin JL; Guinn BA; Penn LZ; Berinstein NL
    Leuk Lymphoma; 2005 Apr; 46(4):581-92. PubMed ID: 16019487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-exposure of human lymphoblastoid cell lines to Epstein-Barr virus.
    Diehl V; Wolf H; Schulte-Holthausen H; zur Hausen H
    Int J Cancer; 1972 Nov; 10(3):641-51. PubMed ID: 4358042
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.
    Cooper NR; Moore MD; Nemerow GR
    Annu Rev Immunol; 1988; 6():85-113. PubMed ID: 2838050
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-phosphorylcholine antibody-producing cells in human lymphoblastoid cell lines established by transformation with Epstein-Barr virus.
    Yoshie O; Ono Y
    Cell Immunol; 1980 Dec; 56(2):305-16. PubMed ID: 6258807
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines.
    Yamamoto N; Mitsuma T; Vogt A
    J Natl Cancer Inst; 1982 Mar; 68(3):385-90. PubMed ID: 6278193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr-related virus from a cynomolgus monkey (Macaca fascicularis).
    Fujimoto K; Terato K; Miyamoto J; Ishiko H; Fujisaki M; Cho F; Honjo S
    J Med Primatol; 1990; 19(1):21-30. PubMed ID: 2160013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.